BackHLS Therapeutics Overview

HLS Therapeutics Intangible Assets

Track HLS Therapeutics's intangible assets ($95M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$95.42M
↓ 17.78% YoYΔ $-20.63M vs prior year quarter

Peer trimmed avg / median

Loading

HLS Therapeutics Intangible Assets History

Loading

HLS Therapeutics vs. peers: Intangible Assets Comparison

Loading

HLS Therapeutics Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

HLS Therapeutics (HLTRF) FAQ

HLS Therapeutics (HLTRF) currently reports a intangible assets of $95M as of June 2026. That compares with $120M in the prior-year period — down 17.8% year over year. Use the charts on this page to explore HLS Therapeutics's intangible assets history and peer comparisons.

HLS Therapeutics's intangible assets decreased from $120M to $95M — a 17.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

HLS Therapeutics reported $95M in intangible assets as of June 2026. That compares with $120M in the prior-year period — down 17.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $95M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for HLS Therapeutics, and consider following HLTRF for alerts when major investors trade the stock.